🌍 Takeda Pharmaceutical Co., Ltd. (TKPHF) - Form 6-K Filing
Filing Date: 2025-10-30
Accepted: 2025-10-30 06:05:26
Event Type: Financial Results
Event Details:
FY2025 H1 Reported Results with CER % ChangeA-4 FY2025 Q2 (Jul-Sep) Core Results withCER % changeA-7 FY2024 H1 Reconciliation from Reported to CoreA-9 FY2023 H1 Net Profit to Adjusted EBITDA BridgeA-15FY2023 LTM Reconciliations to Net Profit and EBITDAA Bridge a-16.
🌍 Takeda Pharmaceutical Co., Ltd. (TKPHF) - Form 6-K Filing
Filing Date: 2025-10-30
Accepted: 2025-10-30 06:05:26
Event Type: Financial Results
Event Details:
💼 Business Developments: